We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 119 results
  1. Dihydromyricetin inhibits Hepatitis B virus replication by activating NF-κB, MAPKs, and autophagy in HepG2.2.15 cells

    Background

    Hepatitis B virus (HBV) infection is a severe global health problem, and there has been no effective method to eliminate HBV. This study...

    Xuefeng Wang, Haiming Hu, ... Hongtao Liu in Molecular Biology Reports
    Article 06 December 2022
  2. Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line

    Hepatitis B virus (HBV) infection remains a major health issue worldwide and the leading cause of cirrhosis and hepatocellular carcinoma (HCC). It...

    Sen Yuan, Yousaf Tanzeel, ... Min Wang in Cell & Bioscience
    Article Open access 17 April 2021
  3. MiR-3677-3p promotes development and sorafenib resistance of hepatitis B-related hepatocellular carcinoma by inhibiting FOXM1 ubiquitination

    Being encoded by hepatitis B, hepatitis B X (HBx) protein plays crucial roles in hepatitis B-related hepatocellular carcinoma (HCC) occurrence,...

    Hengzheng He, Jian Zhou, ... Yangya Quan in Human Cell
    Article 05 July 2023
  4. Catenulopyrizomicins, new anti-Hepatitis B virus compounds, from the rare actinomycete Catenuloplanes sp. MM782L-181F7

    Hepatitis B virus (HBV) causes chronic hepatitis in humans, and current antiviral therapies rarely treat viral infections. To improve the treatment...

    Manabu Yamasaki, Ryuichi Sawa, ... Masayuki Igarashi in The Journal of Antibiotics
    Article 27 November 2023
  5. Synthesis and In vitro Antiproliferative Activity of 5-Halogen-6-nitrobenzo[c][1,2,5]selenadiazoles on A549 Cells

    Abstract

    Selenadiazoles are of a broad spectrum of promising anticancer agents. However, excessive synthetic steps, larger molecular size and erratic...

    Yuanwei Liang, Wenhua Qiu, ... Jian** Chen in Russian Journal of Bioorganic Chemistry
    Article 22 December 2022
  6. Liver Cancer Cells Uptake Labile Iron via L-type Calcium Channel to Facilitate the Cancer Cell Proliferation

    Herein, we studied the effect of labile iron (ferric chloride) on the progression of liver cancer cells (HepG2.2.15). The iron was found to induce...

    Isara Phiwchai, Titipun Thongtem, ... Chalermchai Pilapong in Cell Biochemistry and Biophysics
    Article 16 October 2020
  7. Knockdown of circZMIZ1 enhances the anti-tumor activity of CD8+ T cells to alleviate hepatocellular carcinoma

    ZMIZ1 acts as an oncogene in hepatocellular carcinoma (HCC). circZMIZ1 (hsa_circ_0018964) derives from ZMIZ1; its underlying mechanism in HCC has not...

    ** Li, Anlin Wu, ... Mingming Wu in Functional & Integrative Genomics
    Article 09 February 2024
  8. MiR-222-3p induced by hepatitis B virus promotes the proliferation and inhibits apoptosis in hepatocellular carcinoma by upregulating THBS1

    This study aimed to explore the role of miR-222-3p in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). MiR-222-3p expression in tumor...

    Yongjie Sun, Peng Shi, ... Hong Chang in Human Cell
    Article 17 July 2021
  9. Deubiquitinase OTUD5 promotes hepatitis B virus replication by removing K48-linked ubiquitination of HBV core/precore and upregulates HNF4ɑ expressions by inhibiting the ERK1/2/mitogen-activated protein kinase pathway

    Hepatitis B virus (HBV) infection is a major public health problem worldwide, causing nearly one million deaths annually. OTUD5 is a deubiquitinase...

    Bin Lou, Guanghua Ma, ... Yu Chen in Cellular and Molecular Life Sciences
    Article Open access 28 October 2023
  10. The significance of EphA2-regulated Wnt/β-catenin signal pathway in promoting the metastasis of HBV-related hepatocellular carcinoma

    Background

    Hepatitis B virus (HBV) infection is closely associated with the malignant progression of hepatocellular carcinoma (HCC). However, the...

    Yidan Wang, Zhenting Zhang, ... Jianyu Li in Molecular Biology Reports
    Article 09 November 2022
  11. Phosphorylation of UHRF2 affects malignant phenotypes of HCC and HBV replication by blocking DHX9 ubiquitylation

    Hepatitis B virus (HBV) infection is one of main contributors to poor prognosis and rapid progression of hepatocellular cancer (HCC). We previously...

    Kejia Wu, Yiqi Zhang, ... Changzhu Duan in Cell Death Discovery
    Article Open access 24 January 2023
  12. Epigenetic addition of m5C to HBV transcripts promotes viral replication and evasion of innate antiviral responses

    Eukaryotic five-methylcytosine (m 5 C) is an important regulator of viral RNA splicing, stability, and translation. However, its role in HBV...

    Shuang Ding, Haibin Liu, ... Wuxiang Guan in Cell Death & Disease
    Article Open access 12 January 2024
  13. Hepatocyte steatosis inhibits hepatitis B virus secretion via induction of endoplasmic reticulum stress

    The effects of hepatocyte steatosis on hepatitis B virus (HBV) DNA replication and HBV-related antigen secretion are incompletely understood. The...

    Qichuang Liu, Maoyuan Mu, ... Shide Lin in Molecular and Cellular Biochemistry
    Article 13 May 2021
  14. Dexmedetomidine promotes apoptosis and suppresses proliferation of hepatocellular carcinoma cells via microRNA-130a/EGR1 axis

    Accumulating evidence has revealed the role of microRNAs (miRs) in hepatocellular carcinoma (HCC). Dexmedetomidine, a highly selective α 2 -adrenergic...

    Lei Zhou, Juanni Li, ... Wen Ouyang in Cell Death Discovery
    Article Open access 19 January 2022
  15. Insights into the impact of hepatitis B virus on hepatic stellate cell activation

    During chronic hepatitis B virus (HBV) infection, hepatic fibrosis is a serious pathological condition caused by virus-induced liver damage. The...

    Hongjuan You, **ng Wang, ... Renxian Tang in Cell Communication and Signaling
    Article Open access 11 April 2023
  16. PRKDC promotes hepatitis B virus transcription through enhancing the binding of RNA Pol II to cccDNA

    Hepatitis B virus infection remains a major health problem worldwide due to its high risk of liver failure and hepatocellular carcinoma. Covalently...

    Yao Fan, Yi Liang, ... Hui Fan in Cell Death & Disease
    Article Open access 25 April 2022
  17. Elevated NTCP expression by an iPSC-derived human hepatocyte maintenance medium enhances HBV infection in NTCP-reconstituted HepG2 cells

    Background

    The sodium taurocholate cotransporting polypeptide (NTCP) is a functional receptor for hepatitis B virus (HBV). NTCP-reconstituted human...

    **nlei Li, Zhaohui Xu, ... Zongdi Feng in Cell & Bioscience
    Article Open access 05 July 2021
  18. Minicircle DNA vector expressing interferon-lambda-3 inhibits hepatitis B virus replication and expression in hepatocyte-derived cell line

    Background

    Interferon-alpha (IFNα) is a first-line treatment option for chronic hepatitis B virus (HBV) infection, but the severe systemic...

    **aoyan Guo, Dianke Chen, ... ** Chen in BMC Molecular and Cell Biology
    Article Open access 18 February 2020
  19. Bioactive Compounds of Bhoomi Amla (Phyllanthus niruri): Nutritional and Pharmacological Aspects

    Phyllanthus niruri, a tropical shrub from the family Euphorbiaceae is common in tropical and subtropical regions of the world including India and Sri...
    Chapter 2024
  20. HBx increases chromatin accessibility and ETV4 expression to regulate dishevelled-2 and promote HCC progression

    Hepatitis B virus (HBV) infection is the predominant causes of hepatocellular carcinoma (HCC). HBV X protein (HBx), as the most frequently integrated...

    Chuqian Zheng, Min Liu, ... Hong Fan in Cell Death & Disease
    Article Open access 04 February 2022
Did you find what you were looking for? Share feedback.